Recce Pharmaceuticals Ltd (RCE.AX)
Develops synthetic antibiotics to treat deadly bacterial infections resistant to existing drugs.
0.37+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-2.7%
The outlook
RCE.AX is trading near its 52-week lows, well below both its 50- and 200-day moving averages, reflecting a weak near-term trend. Analyst coverage shows a stark disconnect: the average price target sits significantly above the current price, though sentiment data leans bearish overall. The stock remains highly speculative with limited institutional momentum.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range5% of the way from its 52-week low to high
Price targetAvg target +599% vs current price
Market cap
$109.3M
52-wk high
0.73
52-wk low
0.35
50-day avg
0.45
200-day avg
0.51
Trailing P/E
—